This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Blood Pressure went sky high), COUGH (Bad Cough), DIZZINESS (Dizzy), MYALGIA (Muscle Aches), PYREXIA (High fever), GAIT DISTURBANCE (Have to use a Walker to Walk/ still have to walk with a walker) and FALL (Have fallen 10 times/ kept falling) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (Blood Pressure went sky high) (seriousness criterion hospitalization), COUGH (Bad Cough) (seriousness criterion hospitalization), DIZZINESS (Dizzy) (seriousness criterion hospitalization), MYALGIA (Muscle Aches) (seriousness criterion hospitalization), PYREXIA (High fever) (seriousness criterion hospitalization), GAIT DISTURBANCE (Have to use a Walker to Walk/ still have to walk with a walker) (seriousness criterion hospitalization), FALL (Have fallen 10 times/ kept falling) (seriousness criterion hospitalization), IMPAIRED QUALITY OF LIFE (needed home care after the hospital/could not function as a person/Could not do laundry/had to get a Life Alert System/All patient could do was sleep and sit in a chair) and HEADACHE (Still have remnants of a headache). The patient was treated with Manual therapy (Walker to Walk) for Gait disturbance. At the time of the report, HYPERTENSION (Blood Pressure went sky high), COUGH (Bad Cough), DIZZINESS (Dizzy), MYALGIA (Muscle Aches), PYREXIA (High fever), FALL (Have fallen 10 times/ kept falling) and IMPAIRED QUALITY OF LIFE (needed home care after the hospital/could not function as a person/Could not do laundry/had to get a Life Alert System/All patient could do was sleep and sit in a chair) was resolving and GAIT DISTURBANCE (Have to use a Walker to Walk/ still have to walk with a walker) and HEADACHE (Still have remnants of a headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high (High) Blood Pressure went sky high. On an unknown date, Body temperature: high (High) High fever. On an unknown date, COVID-19: negative (Negative) Did not test positive for Covid-19.         No concomitant products were reported. No treatment drugs were reported It was like patient had Covid-19 but  did not test positive for Covid-19. After 6 month after the 2nd dose patient started to feel better. The patient believes that the Covid-19 shot did more harm than good and is scared to get her booster dose and don't want to be sick again. Company comment: This spontaneous case concerns 62 years old female patient with no medical history provided, who experienced the unexpected serious event Hypertension, Cough, Dizziness, Myalgia, Pyrexia, and Gait disturbance (seriousness criteria hospitalization, medically significant) and unexpected non serious events of Impaired quality of life and Headache which occurred on unknown date after the second dose of mRNA 1273, which required Hospitalization. The patient was treated with Manual therapy (Walker to Walk) for Gait disturbance. The outcome was reported not resolved but reportedly patient felt better after 6 months. The benefit-risk relationship of mRNA-1273 in not affected by this report.    This case was linked to MOD-2021-435816 (Patient Link). Sender's Comments: This spontaneous case concerns 62 years old female patient with no medical history provided, who experienced the unexpected serious event Hypertension, Cough, Dizziness, Myalgia, Pyrexia, and Gait disturbance (seriousness criteria hospitalization, medically significant) and unexpected non serious events of Impaired quality of life and Headache which occurred on unknown date after the second dose of mRNA 1273, which required Hospitalization. The patient was treated with Manual therapy (Walker to Walk) for Gait disturbance. The outcome was reported not resolved but reportedly patient felt better after 6 months. The benefit-risk relationship of mRNA-1273 in not affected by this report.